Cintas CTAS
Cintas scores good on business quality (7.4 of 10). Here is why, in plain words, and what our sealed record shows.
Why it matters
- What Cintas does
Cintas equips businesses with uniforms, first-aid supplies, and facility services, generating steady subscription revenue from millions of workers globally.
- What it does best
Cintas dominates commercial uniform rental through route density that rivals cannot easily match. Its gross margin of 50.7% towers over peer CPRT at 44.7%, reflecting powerful logistics scale.
- The main risk
Citigroup maintains a sell rating with an $181 price target, warning that a rich valuation leaves no margin for error if macro slowdowns pressure commercial uniform rental volumes.
Quality, check by check
Scored against its own industry, from company filings.
Operating margin hits 23.3% while ROE climbs to 41.8%, supported by strong scale efficiencies that expand margins as route density increases.
Route density and customer switching costs build a wide economic moat, landing gross margin in the sector's top quartile at the 82nd percentile.
Revenue grew 8.9% to $11.3B, maintaining a steady expansion trend visible across recent annual periods without dramatic acceleration.
Total debt of $2.4B is well-managed with interest coverage at 24.9x, making debt costs manageable. Free cash flow reached $1.9B, signaling an improving cash profile.
Insiders
Executives and directors, from SEC Form 4 filings we read ourselves. Open market trades only; grants, option exercises and pre-planned sales left out.
2 sold $2.7M outside pre-planned sales.
Our sealed record on CTAS
Verdicts appear here 30 days after we publish them; members see today's. Each one is in the nightly ledger, fingerprinted the night it was made.
The first sealed verdicts appear here on Oct 11, 2026.
Questions
Cintas scores good on the Cluenex quality check (7.4 of 10), measured against its own industry. Profitability is strong, moat strong, growth steady and financial health strong.
In the last 90 days of SEC Form 4 filings: 2 sold $2.7M outside pre-planned sales.
Dec 16, 2026.
See CTAS today
- Today's verdict on CTAS, and why
- Fair value with cautious, base and optimistic cases
- The exact price that would change the verdict
- Which stocks each signal names, the night it fires
Cite this page: Cluenex, “Cintas (CTAS)”, https://cluenex.com/stocks/ctas/, data as of Oct 10, 2026.